Why the 4DMedical (ASX:4DX) share price is reaching new highs

The 4DMedical share price is surging higher today as the company was involved in the Goldman Sachs Healthcare forum

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The 4DMedical Ltd (ASX: 4DX) share price jumped higher today as the company was involved in Goldman Sachs Healthcare Forum. Despite only listing 2 months ago, 4DMedical has taken no time to grab investors' attention, surging almost 20%.

4DMedical shares pushed 14.11% higher to close at a price of $1.90.

What 4D Medical does

Founded in 2012, 4DMedical is a Melbourne based software technology company focused on creating a change in the capacity of physicians to diagnose and manage patients with diseases involving their lungs.

The imaging company is focused on commercialising its '4D' lung imaging technology, which uses patented algorithms to convert X-ray images into quantitative scan data. Unlike existing respiratory diagnostic procedures, its technology provides a non-invasive way of understanding regional lung motion and airflow in real-time. The company's major focus is on US market commercialisation.

So What

The respiratory diagnostic sector represents a global market of over US$31 billion per annum according to Goldman Sachs.

Furthermore, Goldman points out that existing lung diagnostics are outdated. Over the last 200 years, advances in medical diagnostic technology have delivered dramatic benefits for mankind whilst advancements in lung diagnostics have stagnated. The current gold standard modality to diagnose lung dysfunction (Spirometry) was invented in the 1860s.

4DMedical uses its XV technology to change this. Its XV Technology allows physicians to understand airflow within the lung better. The technology leverages existing hardware and software in hospitals to deliver its XV Technology quicker and at a lower cost to existing procedures.

Moreover, the technology operates through a cloud based Software as a Service platform that fully integrates with existing X-ray equipment, alleviating the requirement for hospitals and clinics to make a capital investment.

The Goldman Sachs report outlines the investment opportunity and many investors clearly like what they hear as the 4DMedical share price soars.

Now what

Despite being early days for 4DMedical, the company has wasted no time in getting important TGA approval. This was perhaps aided as a result of the strong tailwinds provided by Covid-19 due to its damaging nature to the lungs.

As if the company doesn't already have enough going for it, 4DMedical also boasts backing by Dr. Sam Hupert, the Co-founder and CEO of Pro Medicus Limited (ASX: PME).

Daniel Ewing owns shares of Pro Medicus Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

These ASX 200 shares could rise 33% to 37%

Analysts at Morgans think these shares could deliver big returns.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but negative day for ASX investors this Thursday.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Guess which ASX 200 stock turned $5,000 into $34,264 in just three years!

Investors have been piling into this ASX 200 stock for years, sending the share price soaring.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why Beach Energy, Meeka Metals, Monash IVF, and Qantas shares are racing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Female miner in hard hat and safety vest on laptop with mining drill in background.
Broker Notes

Experts reveal 2 buys and 1 sell in the ASX 200 materials sector

And they're not all mining companies, either.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Betmakers, Cettire, Johns Lyng, and Vulcan shares are falling today

These shares are having a tough session on Thursday. But why?

Read more »

A smiling miner wearing a high vis vest and yellow hardhat does the thumbs up in front of an open pit copper mine.
Broker Notes

Why Macquarie expects this ASX All Ords copper stock to soar 48% in a year

Macquarie forecasts another big year of gains ahead for this ASX All Ords copper stock. But why?

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

How much upside does Macquarie expect for Steadfast Group shares?

The broker has given its verdict on this blue chip.

Read more »